Issue Date | Title | Author(s) |
2016-08-26 | Adapting the nominal group technique for priority setting of evidence-practice gaps in implementation science | Rankin, NM; McGregor, D; Butow, PN; White, K; Phillips, JL; Young, JM; Pearson, SA; York, S; Shaw, T |
2012-11-22 | Chemotherapy administration: Modelling the costs of alternative protocols | Haywood, P; De Raad, J; Van Gool, K; Haas, M; Gallego, G; Pearson, SA; Faedo, M; Ward, R |
2018-12-01 | Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol | Gisev, N; Pearson, SA; Dobbins, T; Currow, DC; Blyth, F; Larney, S; Dunlop, A; Mattick, RP; Wilson, A; Degenhardt, L |
2017-06-21 | Health care use and costs at the end of life: A comparison of elderly Australian decedents with and without a cancer history | Reeve, R; Srasuebkul, P; Langton, JM; Haas, M; Viney, R; Pearson, SA |
2016-05-24 | Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: A comprehensive analysis from a health payer perspective | Langton, JM; Reeve, R; Srasuebkul, P; Haas, M; Viney, R; Currow, D; Pearson, SA |
2013-02-11 | High risk prescribing in older adults: Prevalence, clinical and economic implications and potential for intervention at the population level | Gnjidic, D; Le Couteur, DG; Pearson, SA; McLachlan, AJ; Viney, R; Hilmer, SN; Blyth, FM; Joshy, G; Banks, E |
2017-10-01 | Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study | Pearce, A; Haas, M; Viney, R; Pearson, SA; Haywood, P; Brown, C; Ward, R |
2019-02-01 | Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: A prospective cohort investigation among adults aged 45 years and over in Australia | Du, W; Gnjidic, D; Pearson, SA; Hilmer, SN; McLachlan, AJ; Blyth, F; Viney, R; Joshy, G; Day, C; Banks, E |
2016-10-01 | Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer | Parkinson, B; Viney, R; Haas, M; Goodall, S; Srasuebkul, P; Pearson, SA |
2015-02-26 | Resource use, costs and quality of end-of-life care: Observations in a cohort of elderly Australian cancer decedents | Langton, JM; Srasuebkul, P; Reeve, R; Parkinson, B; Gu, Y; Buckley, NA; Haas, M; Viney, R; Pearson, SA |
2010-07-16 | Risk factors for colorectal cancer in patients with multiple serrated polyps: A cross-sectional case series from genetics clinics | Buchanan, DD; Sweet, K; Drini, M; Jenkins, MA; Win, AK; English, DR; Walsh, MD; Clendenning, M; McKeone, DM; Walters, RJ; Roberts, A; Pearson, SA; Pavluk, E; Hopper, JL; Gattas, MR; Goldblatt, J; George, J; Suthers, GK; Phillips, KD; Woodall, S; Arnold, J; Tucker, K; Muir, A; Field, M; Greening, S; Gallinger, S; Perrier, R; Baron, JA; Potter, JD; Haile, R; Franke, W; de la Chapelle, A; Macrae, F; Rosty, C; Walker, NI; Parry, S; Young, JP |
2019-01-01 | Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults | Chen, Y; Kirk, MD; Stuart, R; Cheng, AC; Pearson, SA; Hayen, A; Banks, E; Liu, B |
2017-01-01 | Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: Protocol detailing observations in a whole of population cohort | Daniels, B; Lord, SJ; Kiely, BE; Houssami, N; Haywood, P; Lu, CY; Ward, RL; Pearson, SA |